Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyNCT05696717Theravance BiopharmaPhase 3Active not recruiting2026-01Estimated
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseaseNCT05709444PTNPhase 2Completed2024-04-26Actual
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940COMPASS PathwaysPhase 3Active not recruiting2025-11-13Actual
Phase 2b Study of ALTO-100 in MDDNCT05712187Alto NeurosciencePhase 2Completed2024-09-05Actual
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsNCT05712356LSTAPhase 2Completed2026-04-05Actual
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)NCT05712694Polaris GroupPhase 3Terminated2026-05-25Actual
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell TherapyNCT05714345Allogene TherapeuticsPhase 2Terminated2024-02-20Actual
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)NCT05716100XENEPhase 3Recruiting2026-10Estimated
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)NCT05717920ALDXPhase 2Completed2023-11-21Actual
An Open-label Study of XEN1101 in EpilepsyNCT05718817XENEPhase 3Enrolling by invitation2033-04Estimated
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose ExcursionsNCT05721729VOGXPhase 2Completed2024-05-01Actual
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsNCT05725018ABEOPhase 3Active not recruiting2025-09-30Estimated
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.NCT05727904IOVAPhase 3Recruiting2028-03-01Estimated
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderNCT05733546COMPASS PathwaysPhase 2Active not recruiting2025-09Estimated
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCNCT05733598Replimune, Inc.Phase 2Recruiting2027-12-01Estimated
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRCNCT05733611Replimune, Inc.Phase 2Terminated2025-08-18Actual
To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MNCT05733780Bioxytran Inc.Phase 2Unknown2023-12Estimated
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque PsoriasisNCT05739435ALMSPhase 2Active not recruiting2027-12-01Estimated
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeNCT05740007IRWDPhase 2Terminated2025-01-23Actual
Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal HemoglobinuriaNCT05741346BioCryst PharmaceuticalsPhase 2Terminated2025-01-31Actual
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)NCT05742607Innate PharmaPhase 2Recruiting2027-06Estimated
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's DiseaseNCT05744401ALECPhase 2Terminated2025-01-31Actual
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseNCT05759208OKYOPhase 2Completed2023-12-15Actual
Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)NCT05764239SynlogicPhase 3Terminated2024-03-15Actual
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCMNCT05767346CytokineticsPhase 3Completed2025-02-28Actual
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaNCT05768854RAREPhase 3Active not recruiting2025-10-23Actual
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication RegimenNCT05769608MLYSPhase 2Completed2025-01-15Actual
A Study of CDX-0159 in Patients With Eosinophilic EsophagitisNCT05774184Celldex TherapeuticsPhase 2Completed2025-06-04Actual
A Trial of Setmelanotide in Acquired Hypothalamic ObesityNCT05774756RYTMPhase 3Active not recruiting2025-03-18Actual
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)NCT05786573Zenas BioPharma (USA), LLCPhase 3Active not recruiting2026-06-30Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.